Gen-Probe Expects To Meet or Beat High
Profit Expectations--Stock Has Risen 169%
12/18/03
Gen-Probe, up 169% since our buy signal last January, said
it expects their 2004 earnings to meet or beat Wall Street's
already high expectations.
Analysts expect earnings per share of 85
cents. Gen-Probe expects EPS to be anywhere from 85 cents
to 90 cents per share.
Gen-Probe Inc. (ticker: GPRO) manufactures
testing products used for the diagnosis of diseases and screening
of donated human blood. If you missed out on our recommendation
to buy Gen-Probe and the subsequent 169% jump in its price,
then don't delay. Subscribe
today.
|
